UK coronavirus policy could put 7.3 million over-60s at increased risk
The UK’s policy for shielding older adults from COVID-19 overlooks 7.3 million adults aged 60-69, placing them at increased risk and death.
Coronavirus vaccine team secures funding to move towards human trials
Imperial researchers working on a vaccine for COVID-19 have been awarded government funding to take the work forward towards human trials.
Antiviral reducing influenza spread in ferrets could help control flu outbreaks
A new antiviral treatment has been found to reduce the risk of ferrets with influenza spreading the virus to healthy animals.
Rapid lab-free COVID-19 test delivers results in just over an hour
A new DnaNudge Lab-in-Cartridge test is beginning evaluation on patients – requiring no lab and significantly reducing waits for results.
12
Researchers offered support and funding to launch tech startups addressing pain
An Imperial-led accelerator is set to help researchers turn ideas for medical technologies into ventures aimed at understanding and treating pain.
Coronavirus misinformation and vaccine research among key priorities for public
Information overload and conflicting guidance are among the biggest concerns for the public during the current coronavirus outbreak, surveys reveal.
COVID-19 contact tracing apps: 8 privacy questions governments should ask
Imperial experts have posed eight privacy questions governments should consider when developing coronavirus contact tracing apps.
Imperial academics design low cost emergency ventilator
Imperial academics have designed a simple emergency ventilator that can be manufactured quickly and at low cost from generic components.
1
COVID-19: One in five over-80s need hospitalisation and death rate 0.66 per cent
Nearly one in five over-80s infected with COVID-19 are likely to require hospitalisation, compared with around 1 percent of people under 30.
Three Imperial academics win ERC Advanced Grants worth €6.5m
Three Imperial academics have won a combined €6.5m of Europe's most prestigious research funding.
